nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—melanoma—sarcoma	0.228	0.284	CtDrD
Bleomycin—skin cancer—sarcoma	0.212	0.264	CtDrD
Bleomycin—testicular cancer—sarcoma	0.186	0.231	CtDrD
Bleomycin—germ cell cancer—sarcoma	0.178	0.221	CtDrD
Bleomycin—LIG3—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—sarcoma	0.0113	0.227	CbGpPWpGaD
Bleomycin—LIG3—Base Excision Repair—SMUG1—sarcoma	0.00779	0.157	CbGpPWpGaD
Bleomycin—LIG1—mammary gland—sarcoma	0.00458	0.0736	CbGeAlD
Bleomycin—LIG1—Early Phase of HIV Life Cycle—CXCR4—sarcoma	0.00403	0.0814	CbGpPWpGaD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—SMUG1—sarcoma	0.0033	0.0667	CbGpPWpGaD
Bleomycin—LIG1—embryo—sarcoma	0.00313	0.0502	CbGeAlD
Bleomycin—LIG1—Base Excision Repair—SMUG1—sarcoma	0.00302	0.061	CbGpPWpGaD
Bleomycin—LIG3—hematopoietic system—sarcoma	0.00302	0.0485	CbGeAlD
Bleomycin—LIG1—seminal vesicle—sarcoma	0.00294	0.0472	CbGeAlD
Bleomycin—LIG3—connective tissue—sarcoma	0.00291	0.0467	CbGeAlD
Bleomycin—LIG1—hematopoietic system—sarcoma	0.00279	0.0448	CbGeAlD
Bleomycin—LIG1—connective tissue—sarcoma	0.00269	0.0432	CbGeAlD
Bleomycin—BLMH—myometrium—sarcoma	0.00263	0.0422	CbGeAlD
Bleomycin—LIG1—skin of body—sarcoma	0.00243	0.039	CbGeAlD
Bleomycin—BLMH—seminal vesicle—sarcoma	0.00237	0.0381	CbGeAlD
Bleomycin—LIG3—uterus—sarcoma	0.00228	0.0366	CbGeAlD
Bleomycin—BLMH—hematopoietic system—sarcoma	0.00226	0.0362	CbGeAlD
Bleomycin—LIG3—lymphoid tissue—sarcoma	0.00213	0.0341	CbGeAlD
Bleomycin—LIG1—uterus—sarcoma	0.00211	0.0339	CbGeAlD
Bleomycin—LIG1—lymphoid tissue—sarcoma	0.00197	0.0316	CbGeAlD
Bleomycin—BLMH—skin of body—sarcoma	0.00196	0.0315	CbGeAlD
Bleomycin—LIG3—DNA Repair—SMUG1—sarcoma	0.00187	0.0378	CbGpPWpGaD
Bleomycin—LIG1—bone marrow—sarcoma	0.00179	0.0287	CbGeAlD
Bleomycin—BLMH—cardiac atrium—sarcoma	0.00171	0.0275	CbGeAlD
Bleomycin—BLMH—uterus—sarcoma	0.0017	0.0274	CbGeAlD
Bleomycin—LIG3—testis—sarcoma	0.00165	0.0266	CbGeAlD
Bleomycin—LIG1—Vindesine—Vincristine—sarcoma	0.00161	0.484	CbGdCrCtD
Bleomycin—BLMH—lymphoid tissue—sarcoma	0.00159	0.0255	CbGeAlD
Bleomycin—LIG3—liver—sarcoma	0.00156	0.0251	CbGeAlD
Bleomycin—LIG1—testis—sarcoma	0.00153	0.0246	CbGeAlD
Bleomycin—BLMH—tendon—sarcoma	0.00149	0.024	CbGeAlD
Bleomycin—BLMH—bone marrow—sarcoma	0.00145	0.0232	CbGeAlD
Bleomycin—BLMH—testis—sarcoma	0.00124	0.0198	CbGeAlD
Bleomycin—LIG1—Chromosome Maintenance—NPM1—sarcoma	0.0012	0.0243	CbGpPWpGaD
Bleomycin—LIG3—lymph node—sarcoma	0.0012	0.0193	CbGeAlD
Bleomycin—LIG1—S Phase—STAG1—sarcoma	0.00117	0.0236	CbGpPWpGaD
Bleomycin—BLMH—liver—sarcoma	0.00117	0.0188	CbGeAlD
Bleomycin—LIG1—lymph node—sarcoma	0.00111	0.0178	CbGeAlD
Bleomycin—LIG1—Podofilox—Etoposide—sarcoma	0.00102	0.305	CbGdCrCtD
Bleomycin—BLMH—lymph node—sarcoma	0.000896	0.0144	CbGeAlD
Bleomycin—LIG1—DNA Repair—SMUG1—sarcoma	0.000726	0.0147	CbGpPWpGaD
Bleomycin—LIG1—Vinblastine—Vincristine—sarcoma	0.000699	0.21	CbGdCrCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000682	0.0138	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD34—sarcoma	0.000668	0.0135	CbGpPWpGaD
Bleomycin—LIG1—HIV Life Cycle—CXCR4—sarcoma	0.000654	0.0132	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—NPM1—sarcoma	0.00064	0.0129	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PTPRC—sarcoma	0.000483	0.00975	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PLCG1—sarcoma	0.000472	0.00954	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—CXCR4—sarcoma	0.000452	0.00912	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD34—sarcoma	0.000405	0.00818	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—STAG1—sarcoma	0.000398	0.00804	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000362	0.0073	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—STAG1—sarcoma	0.000356	0.00719	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—FOXO1—sarcoma	0.000335	0.00677	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PDGFRB—sarcoma	0.000335	0.00675	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PDGFRA—sarcoma	0.000329	0.00665	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—NPM1—sarcoma	0.000305	0.00617	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTPRC—sarcoma	0.000293	0.00591	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PLCG1—sarcoma	0.000287	0.00578	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCND1—sarcoma	0.000274	0.00552	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ATF1—sarcoma	0.000272	0.0055	CbGpPWpGaD
Bleomycin—Myocardial infarction—Vincristine—sarcoma	0.00027	0.00335	CcSEcCtD
Bleomycin—Pneumonia—Mitoxantrone—sarcoma	0.000269	0.00335	CcSEcCtD
Bleomycin—Stomatitis—Vincristine—sarcoma	0.000268	0.00334	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000267	0.00539	CbGpPWpGaD
Bleomycin—Acute coronary syndrome—Mitoxantrone—sarcoma	0.000264	0.00329	CcSEcCtD
Bleomycin—Hyperaesthesia—Doxorubicin—sarcoma	0.000263	0.00328	CcSEcCtD
Bleomycin—Myocardial infarction—Mitoxantrone—sarcoma	0.000263	0.00327	CcSEcCtD
Bleomycin—Stomatitis—Mitoxantrone—sarcoma	0.000261	0.00325	CcSEcCtD
Bleomycin—Flushing—Dactinomycin—sarcoma	0.000257	0.00319	CcSEcCtD
Bleomycin—Extravasation—Epirubicin—sarcoma	0.000256	0.00318	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KIT—sarcoma	0.000255	0.00516	CbGpPWpGaD
Bleomycin—Haematuria—Mitoxantrone—sarcoma	0.000255	0.00318	CcSEcCtD
Bleomycin—Chills—Thiotepa—sarcoma	0.00025	0.00311	CcSEcCtD
Bleomycin—Chills—Dactinomycin—sarcoma	0.000248	0.00309	CcSEcCtD
Bleomycin—Alopecia—Thiotepa—sarcoma	0.000246	0.00306	CcSEcCtD
Bleomycin—Bronchospasm—Etoposide—sarcoma	0.000246	0.00306	CcSEcCtD
Bleomycin—Hypoaesthesia—Vincristine—sarcoma	0.000246	0.00306	CcSEcCtD
Bleomycin—Alopecia—Dactinomycin—sarcoma	0.000244	0.00304	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CREB1—sarcoma	0.000243	0.00491	CbGpPWpGaD
Bleomycin—Erythema—Thiotepa—sarcoma	0.000242	0.00302	CcSEcCtD
Bleomycin—Haemoglobin—Mitoxantrone—sarcoma	0.000242	0.00301	CcSEcCtD
Bleomycin—Erythema—Dactinomycin—sarcoma	0.000241	0.00299	CcSEcCtD
Bleomycin—Haemorrhage—Mitoxantrone—sarcoma	0.00024	0.00299	CcSEcCtD
Bleomycin—Pancytopenia—Etoposide—sarcoma	0.000237	0.00295	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—sarcoma	0.000237	0.00295	CcSEcCtD
Bleomycin—Ulcer—Epirubicin—sarcoma	0.000236	0.00294	CcSEcCtD
Bleomycin—Pneumonia—Etoposide—sarcoma	0.000224	0.00279	CcSEcCtD
Bleomycin—Anaemia—Thiotepa—sarcoma	0.000224	0.00279	CcSEcCtD
Bleomycin—Ill-defined disorder—Dactinomycin—sarcoma	0.000223	0.00278	CcSEcCtD
Bleomycin—Anaemia—Dactinomycin—sarcoma	0.000222	0.00277	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000221	0.00446	CbGpPWpGaD
Bleomycin—Acute coronary syndrome—Etoposide—sarcoma	0.00022	0.00273	CcSEcCtD
Bleomycin—LIG1—S Phase—MYC—sarcoma	0.000219	0.00443	CbGpPWpGaD
Bleomycin—Ulcer—Doxorubicin—sarcoma	0.000218	0.00272	CcSEcCtD
Bleomycin—Myocardial infarction—Etoposide—sarcoma	0.000218	0.00272	CcSEcCtD
Bleomycin—Alopecia—Vincristine—sarcoma	0.000218	0.00271	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—sarcoma	0.000218	0.00271	CcSEcCtD
Bleomycin—Stomatitis—Etoposide—sarcoma	0.000217	0.0027	CcSEcCtD
Bleomycin—Leukopenia—Thiotepa—sarcoma	0.000217	0.0027	CcSEcCtD
Bleomycin—Malaise—Dactinomycin—sarcoma	0.000217	0.0027	CcSEcCtD
Bleomycin—Chills—Mitoxantrone—sarcoma	0.000216	0.00268	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—sarcoma	0.000216	0.00268	CcSEcCtD
Bleomycin—Leukopenia—Dactinomycin—sarcoma	0.000215	0.00268	CcSEcCtD
Bleomycin—Skin exfoliation—Epirubicin—sarcoma	0.000213	0.00265	CcSEcCtD
Bleomycin—Alopecia—Mitoxantrone—sarcoma	0.000213	0.00264	CcSEcCtD
Bleomycin—Cough—Thiotepa—sarcoma	0.000212	0.00263	CcSEcCtD
Bleomycin—Erythema—Mitoxantrone—sarcoma	0.000209	0.0026	CcSEcCtD
Bleomycin—Myalgia—Thiotepa—sarcoma	0.000206	0.00257	CcSEcCtD
Bleomycin—Myalgia—Dactinomycin—sarcoma	0.000205	0.00255	CcSEcCtD
Bleomycin—BLMH—Immune System—FOXO1—sarcoma	0.000203	0.0041	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PDGFRB—sarcoma	0.000203	0.0041	CbGpPWpGaD
Bleomycin—Discomfort—Dactinomycin—sarcoma	0.000202	0.00252	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—sarcoma	0.000202	0.00251	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—sarcoma	0.000202	0.00251	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—MDM2—sarcoma	0.000201	0.00406	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PDGFRA—sarcoma	0.0002	0.00403	CbGpPWpGaD
Bleomycin—Cystitis—Doxorubicin—sarcoma	0.0002	0.00248	CcSEcCtD
Bleomycin—Confusional state—Thiotepa—sarcoma	0.000199	0.00248	CcSEcCtD
Bleomycin—Hypoaesthesia—Etoposide—sarcoma	0.000199	0.00248	CcSEcCtD
Bleomycin—Anaemia—Vincristine—sarcoma	0.000199	0.00247	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—sarcoma	0.000197	0.00245	CcSEcCtD
Bleomycin—Infection—Thiotepa—sarcoma	0.000197	0.00245	CcSEcCtD
Bleomycin—Oedema—Dactinomycin—sarcoma	0.000196	0.00244	CcSEcCtD
Bleomycin—Infection—Dactinomycin—sarcoma	0.000195	0.00243	CcSEcCtD
Bleomycin—Ill-defined disorder—Mitoxantrone—sarcoma	0.000194	0.00242	CcSEcCtD
Bleomycin—Thrombocytopenia—Thiotepa—sarcoma	0.000194	0.00241	CcSEcCtD
Bleomycin—Anaemia—Mitoxantrone—sarcoma	0.000193	0.00241	CcSEcCtD
Bleomycin—Leukopenia—Vincristine—sarcoma	0.000192	0.00239	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000192	0.00388	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Dactinomycin—sarcoma	0.000192	0.00239	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000192	0.00387	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.00019	0.00384	CbGpPWpGaD
Bleomycin—Malaise—Mitoxantrone—sarcoma	0.000189	0.00235	CcSEcCtD
Bleomycin—Anorexia—Thiotepa—sarcoma	0.000189	0.00235	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—sarcoma	0.000188	0.00234	CcSEcCtD
Bleomycin—Leukopenia—Mitoxantrone—sarcoma	0.000187	0.00233	CcSEcCtD
Bleomycin—Anorexia—Dactinomycin—sarcoma	0.000187	0.00233	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—sarcoma	0.000187	0.00232	CcSEcCtD
Bleomycin—Flushing—Etoposide—sarcoma	0.000186	0.00231	CcSEcCtD
Bleomycin—Myalgia—Vincristine—sarcoma	0.000183	0.00228	CcSEcCtD
Bleomycin—Cough—Mitoxantrone—sarcoma	0.000183	0.00227	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00018	0.00224	CcSEcCtD
Bleomycin—Chills—Etoposide—sarcoma	0.000179	0.00223	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000179	0.00223	CcSEcCtD
Bleomycin—Chest pain—Mitoxantrone—sarcoma	0.000178	0.00222	CcSEcCtD
Bleomycin—Myalgia—Mitoxantrone—sarcoma	0.000178	0.00222	CcSEcCtD
Bleomycin—Paraesthesia—Thiotepa—sarcoma	0.000178	0.00221	CcSEcCtD
Bleomycin—Alopecia—Etoposide—sarcoma	0.000177	0.0022	CcSEcCtD
Bleomycin—Discomfort—Mitoxantrone—sarcoma	0.000176	0.00219	CcSEcCtD
Bleomycin—Oedema—Vincristine—sarcoma	0.000175	0.00218	CcSEcCtD
Bleomycin—Anaphylactic shock—Vincristine—sarcoma	0.000175	0.00218	CcSEcCtD
Bleomycin—Infection—Vincristine—sarcoma	0.000174	0.00217	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—sarcoma	0.000174	0.00217	CcSEcCtD
Bleomycin—LIG1—Disease—TLE1—sarcoma	0.000174	0.00351	CbGpPWpGaD
Bleomycin—Confusional state—Mitoxantrone—sarcoma	0.000172	0.00214	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000172	0.00348	CbGpPWpGaD
Bleomycin—Decreased appetite—Thiotepa—sarcoma	0.000172	0.00214	CcSEcCtD
Bleomycin—Thrombocytopenia—Vincristine—sarcoma	0.000172	0.00214	CcSEcCtD
Bleomycin—Anaphylactic shock—Mitoxantrone—sarcoma	0.000171	0.00213	CcSEcCtD
Bleomycin—Oedema—Mitoxantrone—sarcoma	0.000171	0.00213	CcSEcCtD
Bleomycin—Decreased appetite—Dactinomycin—sarcoma	0.000171	0.00212	CcSEcCtD
Bleomycin—Infection—Mitoxantrone—sarcoma	0.00017	0.00211	CcSEcCtD
Bleomycin—Pain—Thiotepa—sarcoma	0.000169	0.00211	CcSEcCtD
Bleomycin—Pain—Dactinomycin—sarcoma	0.000168	0.00209	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000168	0.00338	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000167	0.00208	CcSEcCtD
Bleomycin—Anorexia—Vincristine—sarcoma	0.000167	0.00208	CcSEcCtD
Bleomycin—Cerebrovascular accident—Epirubicin—sarcoma	0.000165	0.00206	CcSEcCtD
Bleomycin—Hypotension—Vincristine—sarcoma	0.000164	0.00204	CcSEcCtD
Bleomycin—Feeling abnormal—Thiotepa—sarcoma	0.000163	0.00203	CcSEcCtD
Bleomycin—Anorexia—Mitoxantrone—sarcoma	0.000163	0.00203	CcSEcCtD
Bleomycin—Feeling abnormal—Dactinomycin—sarcoma	0.000162	0.00201	CcSEcCtD
Bleomycin—Ill-defined disorder—Etoposide—sarcoma	0.000162	0.00201	CcSEcCtD
Bleomycin—Anaemia—Etoposide—sarcoma	0.000161	0.002	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vincristine—sarcoma	0.00016	0.00199	CcSEcCtD
Bleomycin—Hypotension—Mitoxantrone—sarcoma	0.00016	0.00199	CcSEcCtD
Bleomycin—Paraesthesia—Vincristine—sarcoma	0.000158	0.00196	CcSEcCtD
Bleomycin—Urticaria—Thiotepa—sarcoma	0.000157	0.00196	CcSEcCtD
Bleomycin—Malaise—Etoposide—sarcoma	0.000157	0.00195	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—SRC—sarcoma	0.000157	0.00317	CbGpPWpGaD
Bleomycin—LIG1—Disease—NPM1—sarcoma	0.000157	0.00316	CbGpPWpGaD
Bleomycin—Body temperature increased—Thiotepa—sarcoma	0.000156	0.00195	CcSEcCtD
Bleomycin—Leukopenia—Etoposide—sarcoma	0.000156	0.00194	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000156	0.00194	CcSEcCtD
Bleomycin—Body temperature increased—Dactinomycin—sarcoma	0.000155	0.00193	CcSEcCtD
Bleomycin—BLMH—Immune System—KIT—sarcoma	0.000155	0.00313	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000154	0.00311	CbGpPWpGaD
Bleomycin—Paraesthesia—Mitoxantrone—sarcoma	0.000153	0.00191	CcSEcCtD
Bleomycin—Cerebrovascular accident—Doxorubicin—sarcoma	0.000153	0.0019	CcSEcCtD
Bleomycin—Decreased appetite—Vincristine—sarcoma	0.000153	0.0019	CcSEcCtD
Bleomycin—Dyspnoea—Mitoxantrone—sarcoma	0.000152	0.0019	CcSEcCtD
Bleomycin—Cough—Etoposide—sarcoma	0.000152	0.00189	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000151	0.00305	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—NRAS—sarcoma	0.000151	0.00305	CbGpPWpGaD
Bleomycin—Pain—Vincristine—sarcoma	0.00015	0.00187	CcSEcCtD
Bleomycin—Decreased appetite—Mitoxantrone—sarcoma	0.000149	0.00185	CcSEcCtD
Bleomycin—Chest pain—Etoposide—sarcoma	0.000148	0.00184	CcSEcCtD
Bleomycin—BLMH—Immune System—CREB1—sarcoma	0.000147	0.00298	CbGpPWpGaD
Bleomycin—Discomfort—Etoposide—sarcoma	0.000146	0.00182	CcSEcCtD
Bleomycin—Pain—Mitoxantrone—sarcoma	0.000146	0.00182	CcSEcCtD
Bleomycin—Hypersensitivity—Thiotepa—sarcoma	0.000146	0.00181	CcSEcCtD
Bleomycin—Hypersensitivity—Dactinomycin—sarcoma	0.000145	0.0018	CcSEcCtD
Bleomycin—Confusional state—Etoposide—sarcoma	0.000143	0.00178	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000143	0.00288	CbGpPWpGaD
Bleomycin—Anaphylactic shock—Etoposide—sarcoma	0.000142	0.00177	CcSEcCtD
Bleomycin—Asthenia—Thiotepa—sarcoma	0.000142	0.00177	CcSEcCtD
Bleomycin—Infection—Etoposide—sarcoma	0.000141	0.00176	CcSEcCtD
Bleomycin—Asthenia—Dactinomycin—sarcoma	0.000141	0.00175	CcSEcCtD
Bleomycin—Feeling abnormal—Mitoxantrone—sarcoma	0.000141	0.00175	CcSEcCtD
Bleomycin—Pruritus—Thiotepa—sarcoma	0.00014	0.00174	CcSEcCtD
Bleomycin—Thrombocytopenia—Etoposide—sarcoma	0.000139	0.00173	CcSEcCtD
Bleomycin—Body temperature increased—Vincristine—sarcoma	0.000139	0.00173	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—EGFR—sarcoma	0.000137	0.00277	CbGpPWpGaD
Bleomycin—LIG1—Disease—ENO2—sarcoma	0.000136	0.00274	CbGpPWpGaD
Bleomycin—Urticaria—Mitoxantrone—sarcoma	0.000136	0.00169	CcSEcCtD
Bleomycin—Anorexia—Etoposide—sarcoma	0.000135	0.00169	CcSEcCtD
Bleomycin—Body temperature increased—Mitoxantrone—sarcoma	0.000135	0.00168	CcSEcCtD
Bleomycin—Pancytopenia—Epirubicin—sarcoma	0.000133	0.00166	CcSEcCtD
Bleomycin—Hypotension—Etoposide—sarcoma	0.000133	0.00165	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KRAS—sarcoma	0.00013	0.00262	CbGpPWpGaD
Bleomycin—Hypersensitivity—Vincristine—sarcoma	0.000129	0.00161	CcSEcCtD
Bleomycin—Paraesthesia—Etoposide—sarcoma	0.000128	0.00159	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—sarcoma	0.000127	0.00158	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000127	0.00256	CbGpPWpGaD
Bleomycin—Dyspnoea—Etoposide—sarcoma	0.000127	0.00158	CcSEcCtD
Bleomycin—Hypersensitivity—Mitoxantrone—sarcoma	0.000126	0.00157	CcSEcCtD
Bleomycin—Asthenia—Vincristine—sarcoma	0.000126	0.00157	CcSEcCtD
Bleomycin—Vomiting—Thiotepa—sarcoma	0.000126	0.00157	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—sarcoma	0.000126	0.00156	CcSEcCtD
Bleomycin—Vomiting—Dactinomycin—sarcoma	0.000125	0.00155	CcSEcCtD
Bleomycin—Rash—Thiotepa—sarcoma	0.000125	0.00155	CcSEcCtD
Bleomycin—Dermatitis—Thiotepa—sarcoma	0.000125	0.00155	CcSEcCtD
Bleomycin—Rash—Dactinomycin—sarcoma	0.000124	0.00154	CcSEcCtD
Bleomycin—Decreased appetite—Etoposide—sarcoma	0.000124	0.00154	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—sarcoma	0.000123	0.00153	CcSEcCtD
Bleomycin—Asthenia—Mitoxantrone—sarcoma	0.000123	0.00153	CcSEcCtD
Bleomycin—BLMH—Immune System—MDM2—sarcoma	0.000122	0.00246	CbGpPWpGaD
Bleomycin—Stomatitis—Epirubicin—sarcoma	0.000122	0.00151	CcSEcCtD
Bleomycin—Pain—Etoposide—sarcoma	0.000122	0.00151	CcSEcCtD
Bleomycin—Haematuria—Epirubicin—sarcoma	0.000119	0.00148	CcSEcCtD
Bleomycin—Nausea—Thiotepa—sarcoma	0.000118	0.00146	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—sarcoma	0.000117	0.00146	CcSEcCtD
Bleomycin—Feeling abnormal—Etoposide—sarcoma	0.000117	0.00146	CcSEcCtD
Bleomycin—Nausea—Dactinomycin—sarcoma	0.000117	0.00145	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—sarcoma	0.000116	0.00145	CcSEcCtD
Bleomycin—LIG1—Disease—PLCG1—sarcoma	0.000115	0.00232	CbGpPWpGaD
Bleomycin—Urticaria—Etoposide—sarcoma	0.000113	0.0014	CcSEcCtD
Bleomycin—Haemoglobin—Epirubicin—sarcoma	0.000113	0.0014	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—sarcoma	0.000113	0.0014	CcSEcCtD
Bleomycin—Body temperature increased—Etoposide—sarcoma	0.000112	0.0014	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—sarcoma	0.000112	0.0014	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—sarcoma	0.000112	0.00139	CcSEcCtD
Bleomycin—Vomiting—Vincristine—sarcoma	0.000112	0.00139	CcSEcCtD
Bleomycin—LIG1—Disease—CXCR4—sarcoma	0.000111	0.00223	CbGpPWpGaD
Bleomycin—Rash—Vincristine—sarcoma	0.000111	0.00138	CcSEcCtD
Bleomycin—Dermatitis—Vincristine—sarcoma	0.000111	0.00138	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HRAS—sarcoma	0.00011	0.00223	CbGpPWpGaD
Bleomycin—Haematuria—Doxorubicin—sarcoma	0.00011	0.00137	CcSEcCtD
Bleomycin—BLMH—Immune System—IL2—sarcoma	0.000109	0.0022	CbGpPWpGaD
Bleomycin—Vomiting—Mitoxantrone—sarcoma	0.000109	0.00135	CcSEcCtD
Bleomycin—Rash—Mitoxantrone—sarcoma	0.000108	0.00134	CcSEcCtD
Bleomycin—Dermatitis—Mitoxantrone—sarcoma	0.000108	0.00134	CcSEcCtD
Bleomycin—BLMH—Immune System—JUN—sarcoma	0.000106	0.00214	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CTNNB1—sarcoma	0.000105	0.00212	CbGpPWpGaD
Bleomycin—Hypersensitivity—Etoposide—sarcoma	0.000105	0.0013	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—sarcoma	0.000104	0.0013	CcSEcCtD
Bleomycin—Nausea—Vincristine—sarcoma	0.000104	0.0013	CcSEcCtD
Bleomycin—Flushing—Epirubicin—sarcoma	0.000104	0.00129	CcSEcCtD
Bleomycin—Haemorrhage—Doxorubicin—sarcoma	0.000104	0.00129	CcSEcCtD
Bleomycin—Hypoaesthesia—Doxorubicin—sarcoma	0.000103	0.00128	CcSEcCtD
Bleomycin—Asthenia—Etoposide—sarcoma	0.000102	0.00127	CcSEcCtD
Bleomycin—Nausea—Mitoxantrone—sarcoma	0.000101	0.00126	CcSEcCtD
Bleomycin—Chills—Epirubicin—sarcoma	0.000101	0.00125	CcSEcCtD
Bleomycin—Pruritus—Etoposide—sarcoma	0.000101	0.00125	CcSEcCtD
Bleomycin—Alopecia—Epirubicin—sarcoma	9.91e-05	0.00123	CcSEcCtD
Bleomycin—Erythema—Epirubicin—sarcoma	9.76e-05	0.00121	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—sarcoma	9.63e-05	0.0012	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MDM2—sarcoma	9.56e-05	0.00193	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SRC—sarcoma	9.51e-05	0.00192	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—sarcoma	9.31e-05	0.00188	CbGpPWpGaD
Bleomycin—Chills—Doxorubicin—sarcoma	9.31e-05	0.00116	CcSEcCtD
Bleomycin—Alopecia—Doxorubicin—sarcoma	9.17e-05	0.00114	CcSEcCtD
Bleomycin—BLMH—Immune System—NRAS—sarcoma	9.15e-05	0.00185	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Epirubicin—sarcoma	9.06e-05	0.00113	CcSEcCtD
Bleomycin—Vomiting—Etoposide—sarcoma	9.04e-05	0.00112	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—sarcoma	9.03e-05	0.00112	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—sarcoma	9.02e-05	0.00112	CcSEcCtD
Bleomycin—Rash—Etoposide—sarcoma	8.96e-05	0.00111	CcSEcCtD
Bleomycin—Dermatitis—Etoposide—sarcoma	8.95e-05	0.00111	CcSEcCtD
Bleomycin—Malaise—Epirubicin—sarcoma	8.8e-05	0.0011	CcSEcCtD
Bleomycin—Leukopenia—Epirubicin—sarcoma	8.74e-05	0.00109	CcSEcCtD
Bleomycin—Cough—Epirubicin—sarcoma	8.52e-05	0.00106	CcSEcCtD
Bleomycin—Nausea—Etoposide—sarcoma	8.44e-05	0.00105	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—sarcoma	8.38e-05	0.00104	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—sarcoma	8.35e-05	0.00104	CcSEcCtD
Bleomycin—BLMH—Immune System—EGFR—sarcoma	8.34e-05	0.00168	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—sarcoma	8.33e-05	0.00168	CbGpPWpGaD
Bleomycin—Chest pain—Epirubicin—sarcoma	8.31e-05	0.00103	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—sarcoma	8.31e-05	0.00103	CcSEcCtD
Bleomycin—Discomfort—Epirubicin—sarcoma	8.21e-05	0.00102	CcSEcCtD
Bleomycin—LIG1—Disease—FOXO1—sarcoma	8.17e-05	0.00165	CbGpPWpGaD
Bleomycin—LIG1—Disease—PDGFRB—sarcoma	8.16e-05	0.00165	CbGpPWpGaD
Bleomycin—Malaise—Doxorubicin—sarcoma	8.14e-05	0.00101	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—sarcoma	8.08e-05	0.00101	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—sarcoma	8.03e-05	0.000999	CcSEcCtD
Bleomycin—LIG1—Disease—PDGFRA—sarcoma	8.03e-05	0.00162	CbGpPWpGaD
Bleomycin—Oedema—Epirubicin—sarcoma	7.97e-05	0.000991	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—sarcoma	7.97e-05	0.000991	CcSEcCtD
Bleomycin—Infection—Epirubicin—sarcoma	7.91e-05	0.000985	CcSEcCtD
Bleomycin—Cough—Doxorubicin—sarcoma	7.88e-05	0.000981	CcSEcCtD
Bleomycin—BLMH—Immune System—KRAS—sarcoma	7.88e-05	0.00159	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Epirubicin—sarcoma	7.8e-05	0.00097	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—sarcoma	7.69e-05	0.000957	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—sarcoma	7.69e-05	0.000957	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—sarcoma	7.6e-05	0.000945	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—sarcoma	7.59e-05	0.000945	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—sarcoma	7.47e-05	0.00151	CbGpPWpGaD
Bleomycin—Hypotension—Epirubicin—sarcoma	7.44e-05	0.000926	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—sarcoma	7.43e-05	0.000925	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—sarcoma	7.37e-05	0.000917	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—sarcoma	7.37e-05	0.000917	CcSEcCtD
Bleomycin—Infection—Doxorubicin—sarcoma	7.32e-05	0.000911	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Epirubicin—sarcoma	7.26e-05	0.000903	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—sarcoma	7.22e-05	0.000898	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—sarcoma	7.15e-05	0.00089	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—sarcoma	7.1e-05	0.000884	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—sarcoma	7.03e-05	0.000874	CcSEcCtD
Bleomycin—Decreased appetite—Epirubicin—sarcoma	6.93e-05	0.000862	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—sarcoma	6.89e-05	0.000857	CcSEcCtD
Bleomycin—Pain—Epirubicin—sarcoma	6.81e-05	0.000848	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.72e-05	0.000836	CcSEcCtD
Bleomycin—BLMH—Immune System—HRAS—sarcoma	6.7e-05	0.00135	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—sarcoma	6.68e-05	0.00135	CbGpPWpGaD
Bleomycin—Paraesthesia—Doxorubicin—sarcoma	6.62e-05	0.000824	CcSEcCtD
Bleomycin—Dyspnoea—Doxorubicin—sarcoma	6.57e-05	0.000818	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—sarcoma	6.56e-05	0.000817	CcSEcCtD
Bleomycin—Decreased appetite—Doxorubicin—sarcoma	6.41e-05	0.000797	CcSEcCtD
Bleomycin—Urticaria—Epirubicin—sarcoma	6.33e-05	0.000787	CcSEcCtD
Bleomycin—Pain—Doxorubicin—sarcoma	6.3e-05	0.000784	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—sarcoma	6.3e-05	0.000784	CcSEcCtD
Bleomycin—LIG1—Disease—KIT—sarcoma	6.23e-05	0.00126	CbGpPWpGaD
Bleomycin—Feeling abnormal—Doxorubicin—sarcoma	6.07e-05	0.000756	CcSEcCtD
Bleomycin—LIG1—Disease—CREB1—sarcoma	5.93e-05	0.0012	CbGpPWpGaD
Bleomycin—Hypersensitivity—Epirubicin—sarcoma	5.87e-05	0.00073	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—sarcoma	5.86e-05	0.000729	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—sarcoma	5.83e-05	0.000725	CcSEcCtD
Bleomycin—Asthenia—Epirubicin—sarcoma	5.72e-05	0.000711	CcSEcCtD
Bleomycin—Pruritus—Epirubicin—sarcoma	5.64e-05	0.000701	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—sarcoma	5.48e-05	0.00111	CbGpPWpGaD
Bleomycin—Hypersensitivity—Doxorubicin—sarcoma	5.43e-05	0.000676	CcSEcCtD
Bleomycin—Asthenia—Doxorubicin—sarcoma	5.29e-05	0.000658	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—sarcoma	5.22e-05	0.000649	CcSEcCtD
Bleomycin—Vomiting—Epirubicin—sarcoma	5.07e-05	0.00063	CcSEcCtD
Bleomycin—Rash—Epirubicin—sarcoma	5.02e-05	0.000625	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—sarcoma	5.02e-05	0.000624	CcSEcCtD
Bleomycin—LIG1—Disease—MDM2—sarcoma	4.9e-05	0.00099	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—sarcoma	4.73e-05	0.000589	CcSEcCtD
Bleomycin—Vomiting—Doxorubicin—sarcoma	4.69e-05	0.000583	CcSEcCtD
Bleomycin—Rash—Doxorubicin—sarcoma	4.65e-05	0.000578	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—sarcoma	4.64e-05	0.000578	CcSEcCtD
Bleomycin—Nausea—Doxorubicin—sarcoma	4.38e-05	0.000545	CcSEcCtD
Bleomycin—LIG1—Disease—CTNNB1—sarcoma	4.23e-05	0.000854	CbGpPWpGaD
Bleomycin—LIG1—Disease—SRC—sarcoma	3.82e-05	0.000772	CbGpPWpGaD
Bleomycin—LIG1—Disease—NRAS—sarcoma	3.68e-05	0.000742	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—sarcoma	3.43e-05	0.000692	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—sarcoma	3.35e-05	0.000676	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—sarcoma	3.17e-05	0.000639	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—sarcoma	2.69e-05	0.000543	CbGpPWpGaD
